Cookie Policy         The Babraham Research Campus is also home to The Babraham Institute

  Babraham Bioscience Technologies
        Babraham Research Campus - Cambridge - UK


Video Library


Press Releases and Media Reports 2008



11th December 2008
Cancer Companies at Babraham's Bioincuabtor win Major Awards for Medical Innovation


10th December 2008
Senexis to collaborate with Alzhyme on Alzheimer's diagnostics


4th December 2008
Minister for the East of England visits the Babraham Research Campus and new Technology Development Laboratory


10th September 2008
Pronostics to supply Hannover Medical School with next generation diagnostics for autoimmune disease


5th September 2008
ImmBio-Led Consortium Releases Promising Data for Meningitis B Vaccine


25th July 2008
Pronostics set for European expansion with digital multiplexing solution


18th June 2008
MedCell and NovaThera Merge


9th May 2008
Babraham's 5th Biotechnology Investment Forum draws French Biotech Companies


6th May 2008
Isogenica completes acquisition of the principal assets of Karyon CTT


4th April 2008
Biovitrum's unique neuropathic pain compound is very safe and shows positive effect


1st April 2008
NOVAPOD™ - Anglo-China Manufacturing Agreement Signed Following Market Success


13th March 2008
NovaThera signs Licensing Agreement for 3D Stem Differentiation and Production


12th March 2008
Antibody Engineering Company F-Star Opens Second Research Site in Cambridge, UK


12th March 2008
Pronostics signs distribution agreement with MEDIPAN GmbH to sell its lead products in Europe's largest diagnostics market


19th February 2008
Population Genetics Technologies Raises £3.8M in Series A Funding; Appoints Mel N. Kronick Chief Executive Officer


15th February 2008
Stem Cell Sciences Implements Strategic Reorganisation


14th February 2008
Senexis and O2H (Oxygen Healthcare) announce medicinal chemistry collaboration


6th February 2008
Probe Scientific takes a major step forward with development and distribution plans


5th February 2008
Senexis Joins International Research Consortium: European Union grants £3 million to the consortium for research into the investigation of memory loss in Alzheimer's disease


30th January 2008
Stem Cell Sciences Enters Agreement with Myelin Repair Foundation to Develop Sustainable Cell Sources for CNS Drug Discovery


17th January 2008
Senexis Raises £3.7M from the Wellcome Trust & BTG to Further Develop its Small Molecule Alzheimer's Compounds




Babraham Bioscience Technologies Ltd - Cambridge - United Kingdom